The “lost decade” in emerging markets isn’t over yet, say Srinivasan Sivabalan and Netty Idayu Ismail on Bloomberg. The benchmark MSCI EM index has gained “a paltry 14%” since October 2010, compared to the S&P 500’s near-300% rise over the same period. It has also trailed Europe and Japan.
Foreign investors pulled $90bn out of emerging-market debt and equities in March last year, says Jonathan Wheatley in the Financial Times. The emergency money central banks poured into the global system has since prompted a return: “Almost $790bn has flooded back” into emerging markets since April 2020. The flood of easy money depressed yields in developed markets, encouraging investors to go further afield.
Now tighter US monetary policy could put that process into reverse, triggering a repeat of the 2013 “taper tantrum”, when fears of tightening US monetary policy caused a disruptive sell-off in EM stocks and currencies. The MSCI emerging market index is down this year, while developed markets have rallied, say Sivabalan and Ismail. The ratio between emerging markets and US shares is at a 20-year low. EM stocks trade on roughly a 40% discount to their US peers on a price/earnings (p/e) ratio basis, but “a poorer earnings outlook is discouraging investors from buying into that discount”.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Investors may spy a bargain, but beware, says Chris Dillow in the Investors’ Chronicle. Tighter US monetary policy and a stronger dollar will put stress on companies in the developing world that have borrowed in greenbacks. Some point to the long-term growth prospects of these economies. Yet “[the] link between... growth and equity returns is weak”. Chinese GDP has soared since 1998, but investors would have done better investing in French or Danish stocks over that period.
-
Polar Capital: a cheap, leveraged play on technologyPolar Capital has carved out a niche in fund management and is reaping the benefits
-
Vaccines inject billions into Big Pharma – how to profitThe vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Here's what it means for investors
-
Polar Capital: a cheap, leveraged play on technology
Polar Capital has carved out a niche in fund management and is reaping the benefits
-
Vaccines inject billions into Big Pharma – how to profit from the sector
The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Here's what it means for investors
-
'Investors should keep putting their trust in investment trusts'Interview Peter Walls, manager of the Unicorn Mastertrust fund, analyses investment trusts in a conversation with Andrew Van Sickle
-
Monks Investment Trust is worthy of the spotlightMonks Investment Trust, a global growth trust, sits in the shadow of its stablemate, Scottish Mortgage. But its record warrants attention, says Max King
-
New year, same market forecastsForecasts from banks and brokers are as bullish as ever this year, but there is less conviction about the US, says Cris Sholto Heaton
-
'Expect more policy U-turns from Keir Starmer'Opinion Keir Starmer’s government quickly changes its mind as soon as it runs into any opposition. It isn't hard to work out where the next U-turns will come from
-
Why does Donald Trump want Venezuela's oil?The US has seized control of Venezuelan oil. Why and to what end?
-
Britain heads for disaster – what can be done to fix our economy?Opinion The answers to Britain's woes are simple, but no one’s listening, says Max King
